Bristol settles inventory class action
Executive Summary
Bristol-Myers Squibb has $170 mil. left in its legal reserve for wholesaler inventory litigation after paying $300 mil. to settle a securities class action lawsuit. The settlement is related to inventory accounting and Bristol's investment in ImClone's Erbitux. Bristol increased its legal reserves for wholesaler inventory litigation by $320 mil. to $470 mil. in the second quarter. The $320 mil. reserve was the majority of a $455 mil. second quarter charge for litigation-related expenses. Bristol expected the charge would total $400 mil. (1"The Pink Sheet" July 5, 2004, p. 28)...
You may also be interested in...
Bristol Increases Wholesaler Inventory Liability Legal Reserves By $300 Mil.
Bristol-Myers Squibb plans to increase its legal reserves relating to wholesaler inventory issues by $300 mil., the second increase in three months
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.